Clinical Trial Update: Trial of Artesunate Combination Therapy in Pakistan [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating artesunate combination therapy for uncomplicated Plasmodium falciparum malaria in Pakistan has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Artesunate (artesunate)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Uncomplicated Falciparum Malaria | Phase 2 | Status: COMPLETED